ESC Congress 2018 Session: Impact of gut microbiota on cardiovascular disease Marta Czesnikiewicz-Guzik: Good afternoon, my name is Marta Czesnikiewicz-Guzik and I am from the Department of Periodontology at Glasgow University. I have the pleasure of hosting today for this special European Society of Cardiology edition of Cardiovascular Research Onlife, Professor Dominik Müller from the Experimental and Clinical Research Centre in Berlin. Dominik has significantly contributed to our understanding of the links between salt, immunity, and cardiovascular diseases, and also our understanding of how the gut microbiota contributes to this picture. Welcome Dominik, and thank you very much for joining us at Cardiovascular Research. Dominik N. Müller: Hello! Marta Czesnikiewicz-Guzik: For every researcher, it is crucial to ask important questions and find reliable methods to answer them. As an experienced scientist, how do you find your questions and how do you find reliable methods to answer these questions? Dominik N. Müller: So, the question that we want to ask is often derived from a real life situation. And as you know, we all eat several times a day and, if we eat, we ingest salt-whether we want to or not, we will! The easy question that we asked was whether what we eat and the salt within it, which at a certain stage reaches our gut, will affect our microbes. This was our main research question. We had a study design which relied on animal experiments, cell culture experiments, and a small pilot study in humans. We used animal studies because we can offer them food which they have to eat, different from humans. We gave them a normal salt diet, then switched this to a high salt diet and had a recovery phase again on a normal salt diet. It was a very standardized protocol and we could collect stool samples at every phase. As we are a cardiovascular-experienced lab, we had to team up with experts from the microbiome field. We had partners from MIT in Cambridge (MA) and from EMBL in Heidelberg. Those partnerships were quite instrumental for having the analyses done in the best possible way.
What we found in the beginning was that salt did not affect the animals much. But then, using these novel techniques, statistical analyses, learning machines and so on, we identified bacterial candidates which are regulated by salt and which might be important for cardiovascular health.
We identified Lactobacillus as an interesting salt-sensitive candidate, from which we could produce probiotics and even treat animals which were challenged by high salt to investigate their blood pressure and immune system. Marta Czesnikiewicz-Guzik: Do you think that by targeting the microbiome, we can develop potential novel therapeutic tools? And with respect to this, how could it change clinical practice in the future? Dominik N. Müller: I am not sure whether we are currently at that stage. By doing more research on our microbes and changes which occur due to disease or lifestyle, we might learn what situations are favourable to staying healthy and what conditions might put us at risk. So if we have a clearer picture of this, we might find strategies for how to either change lifestyles or add some compounds like probiotics to restore a healthy equilibrium. This could be something on top of our current understanding of treatments which changes future clinical practice.
Marta Czesnikiewicz-Guzik: Finally the most important question to me as a dentist: everybody is talking about the gut microbiome and its association with cardiovascular health. However, links between periodontitis and cardiovascular health have been studied much earlier, before the gut microbiome become fashionable. What is your opinion on the influence of the oral microbiome on our general health-especially our cardiovascular health? Dominik N. Müller: It is perhaps too early to make a statement on this but what I am convinced of is that our oral microbiome will affect the inflammatory state within our mouth. And since you have said that it is quite obvious there is an association between inflammation in the mouth and general cardiovascular risk, well, we need to learn if this is just a local site of inflammation which is determined by the oral microbiome.
If we push this oral microbiome-immune system homeostasis towards an anti-inflammatory response, would this then affect our whole body and decrease our general cardiovascular risk? This is an open, interesting hypothesisone you might answer in the future! Marta Czesnikiewicz-Guzik: Hopefully! Thank you very much for your time and for joining us at Cardiovascular Research Onlife.
Dominik N. Müller: Thank you.
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